|
|
|
|
|
by klmr
1834 days ago
|
|
No, it doesn’t depend on the definition. This isn’t a point of contention amongst experts. The article you cite is simply wrong (in particular, its claim about the classification of mRNA vaccines as gene therapy in Europe is categorically false), it fundamentally misunderstands how mRNA vaccines work, and it misrepresents the sources it cites supposedly in support. |
|
Gene therapy is a medical field which focuses on the genetic modification of cells to produce a therapeutic effect [1] or the treatment of disease by repairing or reconstructing defective genetic material. [2] — https://en.wikipedia.org/wiki/Gene_therapy
[1] – Kaji, Eugene H. (7 February 2001). "Gene and Stem Cell Therapies". JAMA. 285 (5): 545–550. https://doi.org/10.1001%2Fjama.285.5.545 – ISSN 0098-7484. PMID 11176856.
[2] Ermak G (2015). Emerging Medical Technologies. World Scientific. ISBN 978-981-4675-81-9
—
mRNA vaccines are certainly a more ambiguous fit under the term “gene therapy”, but it can be parsed as such that they are a genetic modification of a viral cell to produce a therapeutic effect. With slightly more ambiguity but not at all without reason, we can parse mRNA vaccines as “the treatment of disease by reconstructing genetic material”. Even if the definition includes the word “defective”. To me the crux of the statement does not appear in the genetic material needing to be “defective”. Via metaphor: We may be unprotected from the elements by our shelter being defective, but it may also occur that shelter is simply missing, such as our immune response to SARS-CoV-2.
I personally wouldn’t call mRNA vaccines gene therapy, but it’s more because it can induce misunderstandings on permanence rather than because of the un-parseability of the smaller term under the larger definition.